X
LH icon

Xponance’s Labcorp LH Stock Holding History

Xponance’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Buy
15,190
+351
+2% +$92.3K 0.03% 426
2026
Q1 		$3.96M Buy
14,839
+603
+4% +$163K 0.03% 411
2025
Q4 		$3.57M Buy
14,236
+1,995
+16% +$530K 0.03% 406
2025
Q3 		$3.51M Sell
12,241
-353
-3% -$94.6K 0.03% 411
2025
Q2 		$3.31M Buy
12,594
+399
+3% +$97.2K 0.03% 425
2025
Q1 		$2.84M Buy
12,195
+195
+2% +$47.3K 0.03% 441
2024
Q4 		$2.75M Buy
12,000
+445
+4% +$102K 0.03% 443
2024
Q3 		$2.58M Sell
11,555
-598
-5% -$131K 0.02% 458
2024
Q2 		$2.47M Sell
12,153
-850
-7% -$173K 0.03% 449
2024
Q1 		$2.84M Buy
13,003
+1,551
+14% +$342K 0.03% 425
2023
Q4 		$2.6M Sell
11,452
-803
-7% -$169K 0.03% 415
2023
Q3 		$2.46M Sell
12,255
-937
-7% -$198K 0.03% 403
2023
Q2 		$2.73M Sell
13,192
-3,649
-22% -$708K 0.04% 380
2023
Q1 		$3.32M Buy
16,841
+4,030
+31% +$829K 0.05% 340
2022
Q4 		$2.59M Sell
12,811
-2,628
-17% -$514K 0.04% 386
2022
Q3 		$2.72M Buy
15,439
+1,324
+9% +$271K 0.05% 322
2022
Q2 		$2.84M Sell
14,115
-15,282
-52% -$3.26M 0.06% 295
2022
Q1 		$6.66M Sell
29,397
-428
-1% -$101K 0.11% 160
2021
Q4 		$8.05M Buy
29,825
+1,310
+5% +$324K 0.13% 148
2021
Q3 		$6.89M Buy
28,515
+10,109
+55% +$2.55M 0.13% 138
2021
Q2 		$4.36M Sell
18,406
-3,402
-16% -$775K 0.08% 203
2021
Q1 		$4.78M Buy
21,808
+77
+0.4% +$15.5K 0.1% 174
2020
Q4 		$3.8M Buy
21,731
+16,523
+317% +$2.85M 0.08% 200
2020
Q3 		$842K Sell
5,208
-42
-0.8% -$6.66K 0.02% 464
2020
Q2 		$749K Buy
+5,250
New +$726K 0.02% 459

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Xponance's LH Position: Q2 2026 in Review

Xponance increased its Labcorp (LH) stake by 2.4% in Q2 2026, buying an estimated $92.3K and bringing the position to 15,190 shares worth $4.25M. The position accounts for 0.03% of the portfolio, ranked #426.

Xponance first reported a position in LH in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.05M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Xponance held 15,190 shares of Labcorp worth $4.25M as of Q2 2026.
  • Xponance bought 351 Labcorp shares in Q2 2026, an estimated $92.3K.
  • Labcorp made up 0.03% of Xponance's portfolio in Q2 2026, its #426 holding.
  • Xponance first reported a position in Labcorp in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Labcorp position peaked at $8.05M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.